TP53 and osteosarcoma: More recent studies [27], [35] show that mice that have homozygous or heterozygous missense mutations of p53 develop tumors with similar latency and spectrum to that of mice that are p53 null or heterozygous, but that they also develop osteosarcomas and carcinomas with higher frequency.